세계의 HTS(High Throughput Screening) 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 제공별, 기술별, 용도별, 최종사용자별, 지역별, 예측(2025-2034년)

The high throughput screening market size is expected to reach USD 93.92 billion by 2034, according to a new study by Polaris Market Research. The report "High Throughput Screening Market Share, Size, Trends, Industry Analysis Report: By Offerings (Consumables, Instruments, Services, Software), Technology, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

High throughput screening (HTS) is an automated method used to rapidly evaluate the biological or biochemical activity of a large number of compounds in a short time. The high throughput screening market growth is increasing due to the emphasis on accelerating early-stage drug discovery services and processes. This technology enables researchers to quickly identify active compounds, antibodies, or genes that modulate a particular biomolecular pathway, thereby streamlining target validation and lead identification. HTS systems are being widely adopted for their speed, precision, and scalability as pharmaceutical and biotech companies seek to enhance research efficiency and reduce development timelines. This growing reliance on high-throughput methodologies is reshaping research workflows across the drug development ecosystem.

The HTS market demand is on the rise due to the integration of artificial intelligence and machine learning into screening platforms. These technologies are improving the predictive power of screening data, enabling more accurate selection of candidate molecules for further development. Researchers can better interpret complex datasets, prioritize high-value targets, and reduce the rate of false positives by leveraging advanced data analytics. This fusion of AI with HTS is transforming traditional drug screening into a more intelligent and cost-effective process. As a result, HTS is evolving beyond simple automation toward becoming a cornerstone of data-driven, next-generation pharmaceutical research strategies.

High Throughput Screening Market Report Highlights

In terms of offering, the consumables segment accounted for the largest high throughput screening market share in 2024, owing to extensive utilization of HTS reagents and assay kits critical for screening workflows.

Based on application, the drug discovery segment led the high throughput screening market in 2024, fueled by intensified pharmaceutical and biotech R&D activities for novel drug development.

North America captured the highest high throughput screening market revenue share in 2024, attributed to substantial R&D investments by pharma-biotech firms targeting chronic disease therapeutics like cancer and CVDs.

The Asia Pacific high throughput screening market is anticipated to grow at the fastest rate, supported by its diverse patient pool driving demand for specialized drug development solutions.

A few global key market players include Agilent Technologies, Inc., Aurora Biomed Inc., Axxam S.p.A., Biomat Srl, Bio-Rad Laboratories, Inc., BMG Labtech GmbH, Brand GmbH+Co KG, Charles River Laboratories, Corning Incorporated, Creative Biolabs, Crown Bioscience, Danaher Corporation, DIANA Biotechnologies, A.S., Eppendorf SE, Eurofins Scientific, Gilson Incorporated, Greiner AG, Hamilton Company, HighRes Biosolutions, Lonza, Merck KGaA, Mettler-Toledo International Inc., Porvair Plc, Revvity, Inc., Sartorius AG, Sygnature Discovery Limited, Tecan Group Ltd., Thermo Fisher Scientific Inc., Waters Corporation.

Polaris Market Research has segmented the high throughput screening market report on the basis of offerings, technology, application, end user, and region:

By Offering Outlook (Revenue, USD Billion, 2020-2034)

Consumables

Reagents & Assay Kits

Laboratory Consumables

Instruments

Liquid Handling Systems

Detection Systems

Imaging Systems

Others

Services

Software

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Cell-based Assays

2D Cell Culture

3D Cell Culture

Scaffold-based Technology

Scaffold-free Technology

Reporter-based Assays

Perfusion Cell Culture

Lab-on-a-Chip Technology (LOC)

Label-free Technology

By Application Outlook (Revenue, USD Billion, 2020-2034)

Drug Discovery

Biochemical Screening

Life Sciences Research

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Contract Research Organizations (CROs)

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global High Throughput Screening Market Insights

• 4.1. High Throughput Screening Market - Market Snapshot
• 4.2. High Throughput Screening Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Demand for Personalized Medicines Driving the Market Growth
    • 4.2.1.2. Technological Advancements in Assay Development Drives the Market Demand
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Data Management and Analysis Challenges
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. High Throughput Screening Market Application Trends
• 4.6. Value Chain Analysis

5. Global High Throughput Screening Market, by Offerings

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
• 5.3. Consumables
  • 5.3.1. Global High Throughput Screening Market, by Consumables, by Region, 2020-2034 (USD Billion)
    • 5.3.1.1. Reagents & Assay Kits
    • 5.3.1.1.1. Global High Throughput Screening Market, by Reagents & Assay Kits, by Region, 2020-2034 (USD Billion)
    • 5.3.1.2. Laboratory Consumables
    • 5.3.1.2.1. Global High Throughput Screening Market, by Laboratory Consumables, by Region, 2020-2034 (USD Billion)
• 5.4. Instruments
  • 5.4.1. Global High Throughput Screening Market, by Instruments, by Region, 2020-2034 (USD Billion)
    • 5.4.1.1. Liquid Handling Systems
    • 5.4.1.1.1. Global High Throughput Screening Market, by Liquid Handling Systems, by Region, 2020-2034 (USD Billion)
    • 5.4.1.2. Detection Systems
    • 5.4.1.2.1. Global High Throughput Screening Market, by Detection Systems, by Region, 2020-2034 (USD Billion)
    • 5.4.1.3. Imaging System
    • 5.4.1.3.1. Global High Throughput Screening Market, by Imaging Systems, by Region, 2020-2034 (USD Billion)
    • 5.4.1.4. Others
    • 5.4.1.4.1. Global High Throughput Screening Market, by Others, by Region, 2020-2034 (USD Billion)
• 5.5. Services
  • 5.5.1.1. Global High Throughput Screening Market, by Services, by Region, 2020-2034 (USD Billion)
• 5.6. Software
  • 5.6.1.1. Global High Throughput Screening Market, by Software, by Region, 2020-2034 (USD Billion)

6. Global High Throughput Screening Market, by Technology

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
• 6.3. Cell-based Assays
  • 6.3.1. Global High Throughput Screening Market, by Cell-based Assays, by Region, 2020-2034 (USD Billion)
  • 6.3.2. 2D Cell Culture
    • 6.3.2.1. Global High Throughput Screening Market, by 2D Cell Culture, by Region, 2020-2034 (USD Billion)
  • 6.3.3. 3D Cell Culture
    • 6.3.3.1. Global High Throughput Screening Market, by 3D Cell Culture, by Region, 2020-2034 (USD Billion)
    • 6.3.3.1.1. Scaffold-based Technology
    • 6.3.3.1.1.1. Global High Throughput Screening Market, by Scaffold-based Technology, by Region, 2020-2034 (USD Billion)
    • 6.3.3.1.2. Scaffold-free Technology
    • 6.3.3.1.2.1. Global High Throughput Screening Market, by Scaffold-free Technology, by Region, 2020-2034 (USD Billion)
  • 6.3.4. Reporter-Based Assays
    • 6.3.4.1. Global High Throughput Screening Market, by Reporter-based Assays, by Region, 2020-2034 (USD Billion)
  • 6.3.5. Perfusion Cell Culture
    • 6.3.5.1. Global High Throughput Screening Market, by Perfusion Cell Culture, by Region, 2020-2034 (USD Billion)
• 6.4. Lab-on-a-Chip Technology (LOC)
  • 6.4.1. Global High Throughput Screening Market, by Lab-on-a-Chip Technology (LOC), by Region, 2020-2034 (USD Billion)
• 6.5. Label-free Technology
  • 6.5.1. Global High Throughput Screening Market, by Label-free Technology, by Region, 2020-2034 (USD Billion)

7. Global High Throughput Screening Market, by Application

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
• 7.3. Drug Discovery
  • 7.3.1. Global High Throughput Screening Market, by Drug Discovery, by Region, 2020-2034 (USD Billion)
• 7.4. Biochemical Screening
  • 7.4.1. Global High Throughput Screening Market, by Biochemical Screening, by Region, 2020-2034 (USD Billion)
• 7.5. Life Sciences Research
  • 7.5.1. Global High Throughput Screening Market, by Life Sciences Research, by Region, 2020-2034 (USD Billion)
• 7.6. Others
  • 7.6.1. Global High Throughput Screening Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global High Throughput Screening Market, by End User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
• 8.3. Pharmaceutical & Biotechnology Companies
  • 8.3.1. Global High Throughput Screening Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
• 8.4. Academic & Research Institutes
  • 8.4.1. Global High Throughput Screening Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)
• 8.5. Contract Research Organizations (CROs)
  • 8.5.1. Global High Throughput Screening Market, by Contract Research Organizations (CROs), by Region, 2020-2034 (USD Billion)
• 8.6. Others
  • 8.6.1. Global High Throughput Screening Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global High Throughput Screening Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. High Throughput Screening Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. High Throughput Screening Market - North America
  • 9.3.1. North America: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
  • 9.3.2. North America: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
  • 9.3.3. North America: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
  • 9.3.4. North America: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.3.5. High Throughput Screening Market - US
    • 9.3.5.1. US: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.3.5.2. US: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.3.5.3. US: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5.4. US: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.3.6. High Throughput Screening Market - Canada
    • 9.3.6.1. Canada: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
• 9.4. High Throughput Screening Market - Europe
  • 9.4.1. Europe: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
  • 9.4.2. Europe: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
  • 9.4.3. Europe: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
  • 9.4.4. Europe: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.4.5. High Throughput Screening Market - UK
    • 9.4.5.1. UK: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.4.6. High Throughput Screening Market - France
    • 9.4.6.1. France: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.4.6.2. France: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.6.3. France: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6.4. France: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.4.7. High Throughput Screening Market - Germany
    • 9.4.7.1. Germany: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.4.8. High Throughput Screening Market - Italy
    • 9.4.8.1. Italy: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.4.9. High Throughput Screening Market - Spain
    • 9.4.9.1. Spain: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.4.10. High Throughput Screening Market - Netherlands
    • 9.4.10.1. Netherlands: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.4.11. High Throughput Screening Market - Russia
    • 9.4.11.1. Russia: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.4.12. High Throughput Screening Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
• 9.5. High Throughput Screening Market - Asia Pacific
  • 9.5.1. Asia Pacific: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.5.5. High Throughput Screening Market - China
    • 9.5.5.1. China: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.5.5.2. China: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.5.3. China: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5.4. China: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.5.6. High Throughput Screening Market - India
    • 9.5.6.1. India: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.5.6.2. India: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.6.3. India: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6.4. India: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.5.7. High Throughput Screening Market - Malaysia
    • 9.5.7.1. Malaysia: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.5.8. High Throughput Screening Market - Japan
    • 9.5.8.1. Japan: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.5.9. High Throughput Screening Market - Indonesia
    • 9.5.9.1. Indonesia: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.5.10. High Throughput Screening Market - South Korea
    • 9.5.10.1. South Korea: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.5.11. High Throughput Screening Market - Australia
    • 9.5.11.1. Australia: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.5.12. High Throughput Screening Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
• 9.6. High Throughput Screening Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.6.5. High Throughput Screening Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.6.6. High Throughput Screening Market - UAE
    • 9.6.6.1. UAE: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.6.7. High Throughput Screening Market - Israel
    • 9.6.7.1. Israel: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.6.8. High Throughput Screening Market - South Africa
    • 9.6.8.1. South Africa: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.6.9. High Throughput Screening Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
• 9.7. High Throughput Screening Market - Latin America
  • 9.7.1. Latin America: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.7.5. High Throughput Screening Market - Mexico
    • 9.7.5.1. Mexico: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.7.6. High Throughput Screening Market - Brazil
    • 9.7.6.1. Brazil: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.7.7. High Throughput Screening Market - Argentina
    • 9.7.7.1. Argentina: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)
  • 9.7.8. High Throughput Screening Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: High Throughput Screening Market, by Offerings, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: High Throughput Screening Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: High Throughput Screening Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: High Throughput Screening Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Agilent Technologies, Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Aurora Biomed Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Axxam S.p.A.
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Biomat Srl
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Bio-Rad Laboratories, Inc.
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. BMG Labtech GmbH
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Brand GmbH+Co KG
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Charles River Laboratories
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Corning Incorporated
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Creative Biolabs
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Crown Bioscience
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Danaher Corporation
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. DIANA Biotechnologies, A.S.
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. Eppendorf SE
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development
• 11.15. Eurofins Scientific
  • 11.15.1. Company Overview
  • 11.15.2. Financial Performance
  • 11.15.3. Product Benchmarking
  • 11.15.4. Recent Development
• 11.16. Gilson Incorporated
  • 11.16.1. Company Overview
  • 11.16.2. Financial Performance
  • 11.16.3. Product Benchmarking
  • 11.16.4. Recent Development
• 11.17. Greiner AG
  • 11.17.1. Company Overview
  • 11.17.2. Financial Performance
  • 11.17.3. Product Benchmarking
  • 11.17.4. Recent Development
• 11.18. Hamilton Company
  • 11.18.1. Company Overview
  • 11.18.2. Financial Performance
  • 11.18.3. Product Benchmarking
  • 11.18.4. Recent Development
• 11.19. HighRes Biosolutions
  • 11.19.1. Company Overview
  • 11.19.2. Financial Performance
  • 11.19.3. Product Benchmarking
  • 11.19.4. Recent Development
• 11.20. Lonza
  • 11.20.1. Company Overview
  • 11.20.2. Financial Performance
  • 11.20.3. Product Benchmarking
  • 11.20.4. Recent Development
• 11.21. Merck KGaA
  • 11.21.1. Company Overview
  • 11.21.2. Financial Performance
  • 11.21.3. Product Benchmarking
  • 11.21.4. Recent Development
• 11.22. Mettler-Toledo International Inc.
  • 11.22.1. Company Overview
  • 11.22.2. Financial Performance
  • 11.22.3. Product Benchmarking
  • 11.22.4. Recent Development
• 11.23. Porvair Plc
  • 11.23.1. Company Overview
  • 11.23.2. Financial Performance
  • 11.23.3. Product Benchmarking
  • 11.23.4. Recent Development
• 11.24. Revvity, Inc.
  • 11.24.1. Company Overview
  • 11.24.2. Financial Performance
  • 11.24.3. Product Benchmarking
  • 11.24.4. Recent Development
• 11.25. Sartorius AG
  • 11.25.1. Company Overview
  • 11.25.2. Financial Performance
  • 11.25.3. Product Benchmarking
  • 11.25.4. Recent Development
• 11.26. Sygnature Discovery Limited
  • 11.26.1. Company Overview
  • 11.26.2. Financial Performance
  • 11.26.3. Product Benchmarking
  • 11.26.4. Recent Development
• 11.27. Tecan Group Ltd.
  • 11.27.1. Company Overview
  • 11.27.2. Financial Performance
  • 11.27.3. Product Benchmarking
  • 11.27.4. Recent Development
• 11.28. Thermo Fisher Scientific Inc.
  • 11.28.1. Company Overview
  • 11.28.2. Financial Performance
  • 11.28.3. Product Benchmarking
  • 11.28.4. Recent Development
• 11.29. Waters Corporation
  • 11.29.1. Company Overview
  • 11.29.2. Financial Performance
  • 11.29.3. Product Benchmarking
  • 11.29.4. Recent Development